| High-volume plasma exchange in patients with acute liver failure: an open randomised controlled trial FS Larsen, LE Schmidt, C Bernsmeier, A Rasmussen, H Isoniemi, ... Journal of hepatology 64 (1), 69-78, 2016 | 606 | 2016 |
| Patients with acute-on-chronic liver failure have increased numbers of regulatory immune cells expressing the receptor tyrosine kinase MERTK C Bernsmeier, OT Pop, A Singanayagam, E Triantafyllou, VC Patel, ... Gastroenterology 148 (3), 603-615. e14, 2015 | 272 | 2015 |
| The role of monocytes and macrophages in acute and acute-on-chronic liver failure E Triantafyllou, KJ Woollard, MJW McPhail, CG Antoniades, LA Possamai Frontiers in immunology 9, 2948, 2018 | 233 | 2018 |
| MerTK expressing hepatic macrophages promote the resolution of inflammation in acute liver failure E Triantafyllou, OT Pop, LA Possamai, A Wilhelm, E Liaskou, ... Gut 67 (2), 333-347, 2018 | 188 | 2018 |
| CD14+ CD15− HLA-DR− myeloid-derived suppressor cells impair antimicrobial responses in patients with acute-on-chronic liver failure C Bernsmeier, E Triantafyllou, R Brenig, FJ Lebosse, A Singanayagam, ... gut 67 (6), 1155-1167, 2018 | 147 | 2018 |
| Secretory leukocyte protease inhibitor: a pivotal mediator of anti‐inflammatory responses in acetaminophen‐induced acute liver failure CG Antoniades, W Khamri, RD Abeles, LS Taams, E Triantafyllou, ... Hepatology 59 (4), 1564-1576, 2014 | 102 | 2014 |
| Multivariate metabotyping of plasma predicts survival in patients with decompensated cirrhosis MJW McPhail, DL Shawcross, MR Lewis, I Coltart, EJ Want, ... Journal of Hepatology 64 (5), 1058-1067, 2016 | 88 | 2016 |
| PD-1 blockade improves Kupffer cell bacterial clearance in acute liver injury E Triantafyllou, CLC Gudd, MA Mawhin, HC Husbyn, FM Trovato, ... The Journal of clinical investigation 131 (4), 2021 | 65 | 2021 |
| CD8+ T cells from patients with cirrhosis display a phenotype that may contribute to cirrhosis-associated immune dysfunction F Lebossé, C Gudd, E Tunc, A Singanayagam, R Nathwani, ... EBioMedicine 49, 258-268, 2019 | 65 | 2019 |
| Increased expression of cytotoxic t-lymphocyte− associated protein 4 by T cells, induced by B7 in sera, reduces adaptive immunity in patients with acute liver failure W Khamri, RD Abeles, TZ Hou, AE Anderson, A El-Masry, E Triantafyllou, ... Gastroenterology 153 (1), 263-276. e8, 2017 | 42 | 2017 |
| Macrophages in chronic liver failure: diversity, plasticity and therapeutic targeting A Singanayagam, E Triantafyllou Frontiers in Immunology 12, 661182, 2021 | 35 | 2021 |
| Expression of AXL receptor tyrosine kinase relates to monocyte dysfunction and severity of cirrhosis R Brenig, OT Pop, E Triantafyllou, A Geng, A Singanayagam, ... Life science alliance 3 (1), 2020 | 33 | 2020 |
| Activation and transcriptional profile of monocytes and CD8+ T cells are altered in checkpoint inhibitor-related hepatitis CLC Gudd, L Au, E Triantafyllou, B Shum, T Liu, R Nathwani, N Kumar, ... Journal of hepatology 75 (1), 177-189, 2021 | 32 | 2021 |
| Dysregulation of the Lysophosphatidylcholine/Autotaxin/Lysophosphatidic Acid Axis in Acute‐on‐Chronic Liver Failure Is Associated With Mortality and Systemic Inflammation by … FM Trovato, R Zia, S Napoli, K Wolfer, X Huang, PE Morgan, H Husbyn, ... Hepatology 74 (2), 907-925, 2021 | 28 | 2021 |
| Lysophosphatidylcholines modulate immunoregulatory checkpoints in peripheral monocytes and are associated with mortality in people with acute liver failure FM Trovato, R Zia, F Artru, S Mujib, E Jerome, A Cavazza, M Coen, ... Journal of hepatology 78 (3), 558-573, 2023 | 19 | 2023 |
| Lipids in liver failure syndromes: a focus on eicosanoids, specialized pro-resolving lipid mediators and lysophospholipids F Artru, MJW McPhail, E Triantafyllou, FM Trovato Frontiers in immunology 13, 867261, 2022 | 12 | 2022 |
| Potential therapies for acute‐on‐chronic liver failure MA Morrison, F Artru, FM Trovato, E Triantafyllou, MJ McPhail Liver International, 2023 | 11 | 2023 |
| Acute alcoholic hepatitis and cellular Th1 immune responses to alcohol dehydrogenase LJ Blackmore, JM Ryan, X Huang, M Hussain, E Triantafyllou, N Vergis, ... The Lancet 385, S22, 2015 | 9 | 2015 |
| Could targeting secretory leukocyte protease inhibitor be an effective therapeutic option to prevent infections in acute liver failure? LA Possamai, W Khamri, E Triantafyllou, JA Wendon, MR Thursz, ... Immunotherapy 6 (6), 667-669, 2014 | 5 | 2014 |
| Suppressor CD4+ T cells expressing HLA-G are expanded in the peripheral blood from patients with acute decompensation of cirrhosis W Khamri, C Gudd, T Liu, R Nathwani, M Krasniqi, S Azam, T Barbera, ... Gut 71 (6), 1192-1202, 2022 | 4 | 2022 |
Mark ThurszProfessor of Hepatology, Imperial CollegeVerificeret mail på imperial.ac.uk
